Last10K.com

Affimed N.V. (AFMD) SEC Filing 20-F Annual Report for the fiscal year ending Thursday, December 31, 2020

Affimed N.V.

HISTORY TOOLS
CIK: 1608390 Ticker: AFMD

View differences made from one year to another to evaluate Affimed N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Affimed N.V..

Continue

Assess how Affimed N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Affimed N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Changes In Equity
Consolidated Statements Of Comprehensive Loss
Consolidated Statements Of Financial Position
1. Reporting Entity
10. Employee Benefits
10. Employee Benefits (Details)
10. Employee Benefits (Tables)
10. Employee Benefits - Narrative (Details)
11. Finance Income And Finance Costs
11. Finance Income And Finance Costs (Details)
11. Finance Income And Finance Costs (Tables)
12. Income Taxes
12. Income Taxes (Details)
12. Income Taxes (Tables)
12. Income Taxes - Narrative (Details)
13. Intangible Assets
13. Intangible Assets (Details)
14. Long Term Financial Assets
14. Long Term Financial Assets (Details)
15. Financial Assets
15. Financial Assets (Details)
16. Other Assets
16. Other Assets (Details)
17. Trade And Other Receivables
17. Trade And Other Receivables (Details)
18. Equity
18. Equity (Details)
19. Share-Based Payments
19. Share-Based Payments (Details)
19. Share-Based Payments (Tables)
19. Share-Based Payments - Additional Information (Details)
2. Local Exemption Rules Applied By Subsidiaries Of The Group
20. Provisions
20. Provisions (Details)
21. Borrowings
21. Borrowings (Tables)
21. Borrowings - Additional Information (Details)
21. Borrowings - Movements Of Liabilities Reconcile To Cash Flows Arising From Financing Activities (Details)
22. Trade And Other Payables
22. Trade And Other Payables (Details)
23. Leases
23. Leases (Tables)
23. Leases - Future Contractually Agreed Undiscounted Lease Payments (Details)
23. Leases - Movements Of Lease Liabilities (Details)
23. Leases - Narrative (Details)
23. Leases - Schedule Of Carrying Amounts Of Right-Of-Use Assets Reconcile (Details)
23. Leases - Schedule Of Cash Outflow Related To Leases (Details)
24. Other Commitments And Contingencies
25. Related Parties
25. Related Parties (Tables)
25. Related Parties - Additional Information (Details)
25. Related Parties - Compensation (Details)
25. Related Parties - Outstanding Balances (Details)
26. Financial Risk Management
26. Financial Risk Management (Tables)
26. Financial Risk Management - Exchange Rates (Details)
26. Financial Risk Management - Narrative (Details)
27. Subsequent Events
27. Subsequent Events (Details)
3. Basis Of Preparation - Consolidated Financial Statements
4. Significant Accounting Policies
4. Significant Accounting Policies (Details)
4. Significant Accounting Policies (Policies)
4. Significant Accounting Policies (Tables)
4. Significant Accounting Policies - Narrative (Details)
4. Significant Accounting Policies - New Standards And Interpretations Not Yet Adopted (Details)
5. Segment Reporting
5. Segment Reporting (Tables)
5. Segment Reporting - Geographic Information (Details)
5. Segment Reporting - Narrative (Details)
6. Revenue
6. Revenue (Details)
6. Revenue (Tables)
6. Revenue - Additional Information (Details)
6. Revenue - Disaggregation Of Revenue (Details)
7. Other Income And Expenses - Net
7. Other Income And Expenses - Net (Details)
8. Research And Development Expenses
8. Research And Development Expenses (Details)
8. Research And Development Expenses (Tables)
9. General And Administrative Expenses
9. General And Administrative Expenses (Details)
9. General And Administrative Expenses (Tables)
Ticker: AFMD
CIK: 1608390
Form Type: 20-F Annual Report
Accession Number: 0001047469-21-000956
Submitted to the SEC: Thu Apr 15 2021 8:01:27 AM EST
Accepted by the SEC: Thu Apr 15 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/afmd/0001047469-21-000956.htm